Insider trades
Benjamin J. Zeskind, CEO of Immuneering IMRX, has filed 5 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $10.9K. The latest trade was on 06/23.
Benjamin J. Zeskind
President and CEO
- Company
- Immuneering IMRX
- First filing
- 23/02/17
- Trades
- 11 trades
- Buys / sales
- 5 / 0
- 12-month net buying
- $10.9K
- Last trade
- 06/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ImmuneeringIMRX | Open-market buy | 06/23 | 06/24 | 2,400 sh | $4.56 | $10,944 | +0.1% |
IMRX | Open-market buy | 25/07/01–25/07/02 | 25/07/03 | 10,000 sh2 trades | $3.49avg. | $34,852.25 | +0.4% |
ImmuneeringIMRX | Open-market buy | 25/06/18 | 25/06/20 | 21,000 sh | $2.39 | $50,190 | +0.9% |
ImmuneeringIMRX | Open-market buy | 24/03/19 | 24/03/19 | 20,000 sh | $2.77 | $55,400 | +0.9% |